98%
921
2 minutes
20
A 45-year-old female with a medical history of systemic lupus erythematosus presented with breast cancer. On postoperative day 26 after undergoing left mastectomy and axillary lymph node dissection, she reported fever and anorexia at the outpatient clinic. Laboratory findings showed pancytopenia, and a subsequent bone marrow biopsy confirmed metastatic breast cancer involving the bone marrow. Tamoxifen and goserelin therapy was started initially. However, on the day after treatment initiation, the patient experienced rapid progression of anemia, with laboratory evidence of hemolysis and clinical signs of jaundice and splenomegaly; this led to a diagnosis of autoimmune hemolytic anemia(AIHA). Steroid pulse therapy resulted in a dramatic halt in anemia progression. Given that AIHA is a paraneoplastic syndrome with suspected resistance to endocrine therapy, chemotherapy with paclitaxel was initiated. AIHA recurrence was not observed after this intervention. In cases of breast cancer with bone marrow metastasis and acute anemia, especially in patients with an autoimmune history, a differential diagnosis beyond marrow suppression from metastasis should be carefully considered.
Download full-text PDF |
Source |
---|
BMC Cancer
September 2025
Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, Jena, 07747, Germany.
Acta Pharmacol Sin
September 2025
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
Chemotherapeutic resistance is a significant issue in the treatment of breast cancer, which is related to pyroptosis inhibition. Increasing evidence suggests that long non-coding RNAs (lncRNAs) contribute to tumorigenesis and drug resistance. In this study we investigated the role of the lncRNA STMN1P2 in doxorubicin resistance in breast cancer, as well as its correlation with pyroptosis inhibition.
View Article and Find Full Text PDFJ Hum Genet
September 2025
Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Comprehensive genomic profiling (CGP) expands treatment options for solid tumor patients and identifies hereditary cancers. However, in Japan, confirmatory tests have been conducted in only 31.6% of patients with presumed germline pathogenic variants (GPVs) detected through tumor-only testing.
View Article and Find Full Text PDFCardiovasc Intervent Radiol
September 2025
The Department of Radiology, Wakayama Medical University, Wakayama, Japan.
Purpose: Recent advancements in medical technologies have made trans-arterial treatment of breast cancer feasible. Consequently, understanding the vascular anatomies of breast cancers and axillary lymph node metastases has become indispensable for sophisticated treatments. The aim of this study was to determine the vascular anatomy of the breast, which is crucial for trans-arterial chemoembolization in patients with breast cancer.
View Article and Find Full Text PDFNat Commun
September 2025
Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, 90033, California, USA.